EUR 0.23
(-1.09%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 7.35 Million EUR | 15.34% |
2022 | 6.32 Million EUR | 31.54% |
2021 | 4.81 Million EUR | -4.1% |
2020 | 5.01 Million EUR | -16.43% |
2019 | 6 Million EUR | -23.03% |
2018 | 7.79 Million EUR | -23.96% |
2017 | 10.25 Million EUR | 3.89% |
2016 | 9.87 Million EUR | 9.42% |
2015 | 9.02 Million EUR | 12.6% |
2014 | 8.01 Million EUR | 10.3% |
2013 | 7.26 Million EUR | 11.16% |
2012 | 6.53 Million EUR | 23.08% |
2011 | 5.3 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 3.55 Million EUR | 0.0% |
2023 Q4 | 3.61 Million EUR | 0.0% |
2023 FY | 7.29 Million EUR | 15.34% |
2023 Q2 | 3.6 Million EUR | 0.0% |
2022 Q2 | 3.05 Million EUR | 0.0% |
2022 Q4 | 3.26 Million EUR | 0.0% |
2022 FY | 6.32 Million EUR | 31.54% |
2021 Q2 | 2.49 Million EUR | 0.0% |
2021 FY | 4.81 Million EUR | -4.1% |
2021 Q4 | 2.31 Million EUR | 0.0% |
2020 Q2 | 2.45 Million EUR | 0.0% |
2020 FY | 5.01 Million EUR | -16.43% |
2020 Q4 | 2.56 Million EUR | 0.0% |
2019 Q2 | 3.32 Million EUR | 0.0% |
2019 FY | 6 Million EUR | -23.03% |
2019 Q4 | 2.73 Million EUR | 0.0% |
2018 FY | 7.79 Million EUR | -23.96% |
2018 Q2 | 3.88 Million EUR | 0.0% |
2018 Q4 | 3.91 Million EUR | 0.0% |
2017 FY | 10.25 Million EUR | 3.89% |
2017 Q2 | 5.45 Million EUR | 0.0% |
2017 Q4 | 4.79 Million EUR | 0.0% |
2016 FY | 9.87 Million EUR | 9.42% |
2016 Q2 | 5.28 Million EUR | 0.0% |
2016 Q4 | 4.58 Million EUR | 0.0% |
2015 Q4 | 4.39 Million EUR | 0.0% |
2015 Q2 | 4.63 Million EUR | 0.0% |
2015 FY | 9.02 Million EUR | 12.6% |
2014 Q4 | 3.88 Million EUR | 0.0% |
2014 Q2 | 4.12 Million EUR | 0.0% |
2014 FY | 8.01 Million EUR | 10.3% |
2013 Q4 | 3.72 Million EUR | 0.0% |
2013 FY | 7.26 Million EUR | 11.16% |
2013 Q2 | 3.53 Million EUR | 0.0% |
2012 Q1 | 424.50 EUR | 0.0% |
2012 Q2 | 424.50 EUR | 0.0% |
2012 Q3 | 424.50 EUR | 0.0% |
2012 FY | 6.53 Million EUR | 23.08% |
2012 Q4 | -53.05 Thousand EUR | -12597.29% |
2011 Q2 | 1.28 Million EUR | 0.0% |
2011 Q1 | 1.28 Million EUR | 0.0% |
2011 Q3 | 1.28 Million EUR | 0.0% |
2011 Q4 | 424.50 EUR | -99.97% |
2011 FY | 5.3 Million EUR | 0.0% |
2010 Q4 | 1.28 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Affluent Medical SA | 11.86 Million EUR | 38.015% |
Bluelinea Société Anonyme | 11.43 Thousand EUR | -64198.89% |
Carmat SA | 21.54 Million EUR | 65.866% |
Diagnostic Medical Systems S.A. | 18.1 Million EUR | 59.382% |
Euromedis Groupe | 17.6 Million EUR | 58.231% |
Eurobio Scientific Société anonyme | 47.34 Million EUR | 84.465% |
Ikonisys S.A. | 2.44 Million EUR | -200.265% |
Implanet S.A. | 9.29 Million EUR | 20.836% |
Median Technologies SA | 46.34 Million EUR | 84.129% |
Theraclion SA | -1.08 Million EUR | 780.79% |
Euroapi S.A. | 398.9 Million EUR | 98.156% |
Guerbet SA | 550.79 Million EUR | 98.665% |
Ion Beam Applications SA | 128.02 Million EUR | 94.255% |
Koninklijke Philips N.V. | 5.84 Billion EUR | 99.874% |
Sequana Medical NV | 30.03 Million EUR | 75.515% |